Literature DB >> 27383183

Altered TGF-α/β signaling drives cooperation between breast cancer cell populations.

Omar E Franco1, Darren R Tyson2, Katherine C Konvinse3, Akshata R Udyavar2, Lourdes Estrada2, Vito Quaranta2, Susan E Crawford1, Simon W Hayward4.   

Abstract

The role of tumor heterogeneity in regulating disease progression is poorly understood. We hypothesized that interactions between subpopulations of cancer cells can affect the progression of tumors selecting for a more aggressive phenotype. We developed an in vivo assay based on the immortalized nontumorigenic breast cell line MCF10A and its Ras-transformed derivatives AT1 (mildly tumorigenic) and CA1d (highly tumorigenic). CA1d cells outcompeted MCF10A, forming invasive tumors. AT1 grafts were approximately 1% the size of CA1d tumors when initiated using identical cell numbers. In contrast, CA1d/AT1 mixed tumors were larger than tumors composed of AT1 alone (100-fold) or CA1d (3-fold), suggesting cooperation in tumor growth. One of the mechanisms whereby CA1d and AT1 were found to cooperate was by modulation of TGF-α and TGF-β signaling. Both of these molecules were sufficient to induce changes in AT1 proliferative potential in vitro. Reisolation of AT1 tumor-derived (AT1-TD) cells from these mixed tumors revealed that AT1-TD cells grew in vivo, forming tumors as large as tumorigenic CA1d cells. Cooperation between subpopulations of cancer epithelium is an understudied mechanism of tumor growth and invasion that may have implications on tumor resistance to current therapies.-Franco, O. E., Tyson, D. R., Konvinse, K. C., Udyavar, A. R., Estrada, L., Quaranta, V., Crawford, S. E., Hayward, S. W. Altered TGF-α/β signaling drives cooperation between breast cancer cell populations. © FASEB.

Entities:  

Keywords:  epithelial paracrine interactions; intratumor cooperation; tumor heterogeneity

Mesh:

Substances:

Year:  2016        PMID: 27383183      PMCID: PMC5024699          DOI: 10.1096/fj.201500187RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

1.  Role for stromal heterogeneity in prostate tumorigenesis.

Authors:  Maria A Kiskowski; Roger S Jackson; Jheelam Banerjee; Xiaohong Li; Minchul Kang; Juan M Iturregui; Omar E Franco; Simon W Hayward; Neil A Bhowmick
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

Review 2.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

3.  High-resolution characterization of the pancreatic adenocarcinoma genome.

Authors:  Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark S Redston; Ronald A DePinho; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

Review 4.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

5.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

Review 6.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

Review 7.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

8.  Tumor heterogeneity in neoplasms of breast, colon, and skin.

Authors:  Jian Li; Kai Wang; Thomas Dyrsø Jensen; Shengting Li; Lars Bolund; Carsten Wiuf
Journal:  BMC Res Notes       Date:  2010-11-25

9.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  Heterogeneous tumor subpopulations cooperate to drive invasion.

Authors:  Anna Chapman; Laura Fernandez del Ama; Jennifer Ferguson; Jivko Kamarashev; Claudia Wellbrock; Adam Hurlstone
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

View more
  5 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.

Authors:  Swathi Karthikeyan; Ian G Waters; Lauren Dennison; David Chu; Joshua Donaldson; Dong Ho Shin; D Marc Rosen; Paula I Gonzalez-Ericsson; Violeta Sanchez; Melinda E Sanders; Morgan V Pantone; Riley E Bergman; Brad A Davidson; Sarah C Reed; Daniel J Zabransky; Karen Cravero; Kelly Kyker-Snowman; Berry Button; Hong Yuen Wong; Paula J Hurley; Sarah Croessmann; Ben Ho Park
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 3.  Non-autonomous cell proliferation in the mammary gland and cancer.

Authors:  Robert J Weber; Tejal A Desai; Zev J Gartner
Journal:  Curr Opin Cell Biol       Date:  2017-03-15       Impact factor: 8.382

4.  Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST.

Authors:  Jo Anne Stratton; Peggy Assinck; Sarthak Sinha; Ranjan Kumar; Aaron Moulson; Natalya Patrick; Eko Raharjo; Jennifer A Chan; Rajiv Midha; Wolfram Tetzlaff; Jeff Biernaskie
Journal:  Front Cell Neurosci       Date:  2018-10-11       Impact factor: 5.505

Review 5.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.